GLPwatch
Trials (2081)
Page 4 of 35.
- Semaglutide and Preoperative Residual Gastric Volumes
- A Study on How NNC0174-1213 Works in People With Overweight or Obesity.
- The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes
- Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy
- GLP-1s to Enhance Lasting Optimal Weight
- Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
- A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes
- A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
- Semaglutide Treatment On Coronary Progression
- Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
- A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) Impairment
- Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
- Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
- Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira
- A Study of Orforglipron (LY3502970) to Compare a Single Capsule and Multiple Capsules in Healthy Participants
- Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
- Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users
- Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
- Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis
- Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease
- Tailoring Obesity Treatment Trial
- Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters
- 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
- Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects
- A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus
- SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
- 2024 Tirzepatide-Bariatric Surgery
- Semaglutide in CFRD
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea
- Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes
- Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery
- Tirzepatide and Muscle Outcomes in Obesity
- LY2189265 and Atorvastatin Interaction Study
- Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin
- Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
- Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
- A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics
- Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes
- A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
- Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
- Liraglutide and Peripheral Artery Disease
- Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide
- Pemvidutide (ALT-801) DDI Study in Healthy Volunteers
- Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes
- Glucagon-like Peptide (GLP) Utilization and Safety
- GLP1R Polymorphisms and Response to GLP1
- Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus
- A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight
- Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care
- Evaluating Liraglutide in Alzheimer's Disease
- Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy
- Preoperative Optimization With Tirzepatide, Ketogenic Diet, or Standard Care Before One Anastomosis Gastric Bypass Surgery
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
- The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
- A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes
- Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy
- Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
- A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes